SCHEMBL6285213

SCHEMBL6285213

c1cc(-c2nccc3nncn23)ccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.38
▸ MAPK9 P45984 2/20 0.38
▸ MAPK10 P53779 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ADORA2A P29274 3/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ EED O75530 1/20 0.33
▸ SUZ12 Q15022 1/20 0.33
▸ EZH2 Q15910 1/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11391249 0.86 POLB (0.49) MAPK9L3MBTL1KDM4EALDH1A1HPGD
SCHEMBL6285208 0.76 KDM4E (0.46) HTTMAPK9MAPK10L3MBTL1KDM4E
SCHEMBL23176173 0.73 SMN1; SMN2 (0.40) KDM4EALDH1A1ADORA2APOLBLMNA
SCHEMBL6286431 0.73 MAPK9 (0.42) MAPK9MAPK10L3MBTL1KDM4EALDH1A1
SCHEMBL11386388 0.71 KDM4E (0.54) KDM4EALDH1A1CYP1A2HPGDPOLB
SCHEMBL23143395 0.68 KDR (0.42) HTTMAPK9MAPK10ADORA2AMAPT
SCHEMBL23331067 0.67 TOP2A (0.35) ALDH1A1EEDSMN1; SMN2MAPK1
SCHEMBL2451213 0.66 L3MBTL1 (0.49) MAPK9MAPK10L3MBTL1KDM4EALDH1A1
SCHEMBL25169867 0.66 ABL1 (0.54) HTTL3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL21672427 0.66 SMN1; SMN2 (0.33) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921762-B2 Substituted indolizine-like compounds and methods of use AMGEN INC. (US) 2005-07-26 — — US disclosed
Send feedback